Development of multi-drug resistance to anticancer drugs in HepG2 cells due to MRP2 upregulation on exposure to menthol
Main Authors: | Katsuhito Nagai, Mayuko Tamura, Ryuga Murayama, Shuhei Fukuno, Takuya Ito, Hiroki Konishi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513270/?tool=EBI |
Similar Items
-
Development of multi-drug resistance to anticancer drugs in HepG2 cells due to MRP2 upregulation on exposure to menthol.
by: Katsuhito Nagai, et al.
Published: (2023-01-01) -
NHERF1/EBP50 as a Target for Modulation of MRP Function in HepG2 Cells
by: Atsushi Kawase, et al.
Published: (2021-03-01) -
Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System
by: Ryosuke Negoro, et al.
Published: (2022-05-01) -
Role of oxidative stress in antituberculous drugs (individuals and combined) cytotoxicity in HepG2 cells
by: Elmorsy, Ekramy, et al.
Published: (2016) -
Allicin and Capsaicin Ameliorated Hypercholesterolemia by Upregulating LDLR and Downregulating PCSK9 Expression in HepG2 Cells
by: Nantiya Nawaka, et al.
Published: (2022-11-01)